| Metric | Value (₹ Cr) | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue | 2.4K | 4.4% | 17.8% |
| Total Income | 2.4K | 4.2% | 16.9% |
| Expenditure | 2.0K | 3.7% | 17.1% |
| PBT | 317.98 | 21.3% | 37.1% |
| Net Profit | 271.19 | 37.4% | 44.2% |
| OPM | 21.98% | 1.68pp | 2.95pp |
| NPM | 11.45% | 2.77pp | 2.17pp |
| EPS | 3.52 | 37.0% | 44.3% |
Fortis Healthcare FY26 PAT up 31.5% to ₹1,064 Cr
22 May 2026 · 22 May, 8:52 pm
Summary
Fortis Healthcare Ltd. reported strong financial performance for both Q4 FY26 and the full fiscal year FY26. Consolidated revenues for Q4 FY26 grew 17.8% year-over-year to ₹2,365 crore, while full-year FY26 revenues increased by 17.3% to ₹9,128 crore. The company saw a significant improvement in profitability, with Q4 FY26 Profit After Tax soaring by 44.2% to ₹271 crore and full-year PAT rising 31.5% to ₹1,064 crore. Operating EBITDA margins expanded to 22.5% in Q4 FY26 and 22.8% for the full year, up from 21.7% and 20.4% respectively. The Board has also recommended a dividend of ₹1 per share.
Key Highlights
- 1
Consolidated revenues for Q4 FY26 reached ₹2,365 crore, marking a significant 17.8% increase year-over-year.
- 2
For the full fiscal year FY26, consolidated revenues stood at ₹9,128 crore, reflecting a robust 17.3% growth compared to FY25.
- 3
Operating EBITDA for Q4 FY26 increased by 22.2% to ₹531 crore, with margins improving to 22.5% from 21.7% in Q4 FY25.
- 4
Full-year FY26 Operating EBITDA grew by 31.3% to ₹2,085 crore, with margins expanding to 22.8% from 20.4% in FY25.
- 5
Profit After Tax for Q4 FY26 surged by 44.2% to ₹271 crore, while FY26 PAT rose by 31.5% to ₹1,064 crore.
- 6
The Board of Directors recommended a dividend of ₹1 per share, representing 10% of the face value.
- 7
Net debt as of March 31, 2026, was ₹2,334 crore, with a Net Debt to EBITDA ratio of 1.09x.
Informational and educational content only. Not investment advice.